Advertisement
Advertisement

AIM

AIM logo

AIM ImmunoTech Inc.

0.37
USD
Sponsored
+0.01
+3.00%
Jun 24, 15:59 UTC -4
Closed
exchange

Pre-Market

0.36

-0.01
-2.41%

AIM Earnings Reports

Positive Surprise Ratio

AIM beat 14 of 31 last estimates.

45%

Next Report

Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.17
Implied change from Q1 26 (Revenue/ EPS)
-100.00%
/
-69.64%
Implied change from Q2 25 (Revenue/ EPS)
-100.00%
/
-95.37%

AIM ImmunoTech Inc. earnings per share and revenue

On May 15, 2026, AIM reported earnings of -0.56 USD per share (EPS) for Q1 26, missing the estimate of -0.37 USD, resulting in a -52.53% surprise. Revenue reached 22.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a +61.26% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.17 USD, with revenue projected to reach -- USD, implying an decrease of -69.64% EPS, and decrease of -100.00% in Revenue from the last quarter.
FAQ
For Q1 2026, AIM ImmunoTech Inc. reported EPS of -$0.56, missing estimates by -52.53%, and revenue of $22.00K, 0% as expectations.
The stock price moved up 61.26%, changed from $0.25 before the earnings release to $0.41 the day after.
The next earning report is scheduled for Aug 12, 2026.
Based on 3 analysts, AIM ImmunoTech Inc. is expected to report EPS of -$0.17 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement